Literature DB >> 2707301

Involvement of 5-HT receptor subtypes in the discriminative stimulus properties of mescaline.

J B Appel1, P M Callahan.   

Abstract

In order to further evaluate the extent to which particular 5-HT receptor subtypes (5-HT1, 5-HT2) might be involved in the behavioral effects of hallucinogenic drugs, rats were trained to discriminate mescaline (10 mg/kg i.p.) from saline and were given substitution (generalization) and combination (antagonism) tests with putatively selective serotonergic and related neuroactive compounds. The mescaline cue generalized to relatively high doses of the 5-HT2 agonists, 2,5-dimethoxy-4-methylamphetamine (DOM), LSD and psilocybin; the extent of generalization to 5-HT1 agonists (8-hydroxy-2-[diethylamino]tetralin (8-OHDPAT), RU-24969 and 8-hydroxy-2-[di-n-propylamino]tetralin (TFMPP] was unclear. Combinations of the training drug and sufficiently high doses of 5-HT2 antagonists (ketanserin, LY-53857, pirenperone) were followed by saline-lever responding; less selective central 5-HT (metergoline), and DA (SCH-23390, haloperidol) antagonists, did not block the mescaline cue. These data suggest that 5-HT2 receptors are involved in the stimulus properties of mescaline.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2707301     DOI: 10.1016/0014-2999(89)90041-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

Review 1.  The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act.

Authors:  Matthew W Johnson; Roland R Griffiths; Peter S Hendricks; Jack E Henningfield
Journal:  Neuropharmacology       Date:  2018-06-05       Impact factor: 5.250

2.  Determining the subjective and physiological effects of BZP combined with TFMPP in human males.

Authors:  Joanne C Lin; Reem K Jan; HeeSeung Lee; Maree-Ann Jensen; Rob R Kydd; Bruce R Russell
Journal:  Psychopharmacology (Berl)       Date:  2011-04       Impact factor: 4.530

3.  Ketamine for Depression: Advances in Clinical Treatment, Rapid Antidepressant Mechanisms of Action, and a Contrast with Serotonergic Psychedelics.

Authors:  Marina Kojic; Johan Saelens; Bashkim Kadriu; Carlos A Zarate; Christoph Kraus
Journal:  Curr Top Behav Neurosci       Date:  2022

4.  Novel, unifying mechanism for mescaline in the central nervous system: electrochemistry, catechol redox metabolite, receptor, cell signaling and structure activity relationships.

Authors:  Peter Kovacic; Ratnasamy Somanathan
Journal:  Oxid Med Cell Longev       Date:  2009 Sep-Oct       Impact factor: 6.543

Review 5.  Recent advances in the neuropsychopharmacology of serotonergic hallucinogens.

Authors:  Adam L Halberstadt
Journal:  Behav Brain Res       Date:  2014-07-15       Impact factor: 3.332

6.  Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines.

Authors:  J C Winter
Journal:  Psychopharmacology (Berl)       Date:  2008-11-01       Impact factor: 4.530

7.  Psilocybin-induced stimulus control in the rat.

Authors:  J C Winter; K C Rice; D J Amorosi; R A Rabin
Journal:  Pharmacol Biochem Behav       Date:  2007-06-22       Impact factor: 3.533

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.